Patents by Inventor Daniel Rachmilewitz

Daniel Rachmilewitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7560436
    Abstract: The present invention provides methods of treating gastrointestinal inflammation, methods of treating inflammatory bowel disease, methods of treating Crohn's Disease, and methods of treating ulcerative colitis in an individual. The methods generally involve administering an effective amount of an agent that increases the level of a Type I interferon and/or that activates a Type I interferon signaling pathway in the individual.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: July 14, 2009
    Assignee: The Regents of the University of California
    Inventors: Eyal Raz, Kyoko Katakura, Jongdae Lee, Daniel Rachmilewitz
  • Patent number: 7485627
    Abstract: The invention provides a method for ameliorating gastrointestinal inflammation, particularly chronic gastrointestinal inflammation such as inflammatory bowel disease (IBD), in a subject. In one embodiment, the method comprises administering an immunomodulatory nucleic acid to a subject suffering from or susceptible to gastrointestinal inflammation.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: February 3, 2009
    Assignees: The Regents of the University of California, Tel Aviv Sourasky Medical Center
    Inventors: Eyal Raz, Daniel Rachmilewitz
  • Publication number: 20080008741
    Abstract: The present invention provides methods of treating irritable bowel syndrome (IBS) in an individual suffering from IBS. The methods generally involve administering to the individual an effective amount of a therapeutic nucleic acid. The invention further provides kits and compositions for practicing the subject methods.
    Type: Application
    Filed: January 27, 2005
    Publication date: January 10, 2008
    Inventors: Eyal Raz, Daniel Rachmilewitz
  • Publication number: 20070004654
    Abstract: The present invention provides methods of treating gastrointestinal inflammation, methods of treating inflammatory bowel disease, methods of treating Crohn's Disease, and methods of treating ulcerative colitis in an individual. The methods generally involve administering an effective amount of an agent that increases the level of a Type I interferon and/or that activates a Type I interferon signaling pathway in the individual.
    Type: Application
    Filed: February 21, 2006
    Publication date: January 4, 2007
    Inventors: Eyal Raz, Kyoko Katakura, Jongdae Lee, Daniel Rachmilewitz
  • Publication number: 20050180962
    Abstract: The present invention provides formulations comprising inactivated probiotic bacteria, and treatment methods using the formulations.
    Type: Application
    Filed: December 18, 2003
    Publication date: August 18, 2005
    Inventors: Eyal Raz, Daniel Rachmilewitz
  • Publication number: 20030176389
    Abstract: The invention provides a method for ameliorating gastrointestinal inflammation, particularly chronic gastrointestinal inflammation such as inflammatory bowel disease (IBD), in a subject. In one embodiment, the method comprises administering an immunomodulatory nucleic acid to a subject suffering from or susceptible to gastrointestinal inflammation.
    Type: Application
    Filed: April 11, 2003
    Publication date: September 18, 2003
    Inventors: Eyal Raz, Daniel Rachmilewitz
  • Patent number: 6613751
    Abstract: The invention provides a method for ameliorating gastrointestinal inflammation, particularly chronic gastrointestinal inflammation such as inflammatory bowel disease (IBD), in a subject. In one embodiment, the method comprises administering an immunomodulatory nucleic acid to a subject suffering from or susceptible to gastrointestinal inflammation.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: September 2, 2003
    Assignees: The Regents of the University of California, Tel Aviv Sourasky Medical Center
    Inventors: Eyal Raz, Daniel Rachmilewitz
  • Publication number: 20030130217
    Abstract: The invention provides a method for ameliorating gastrointestinal inflammation, particularly chronic gastrointestinal inflammation such as inflammatory bowel disease (IBD), in a subject. In one embodiment, the method comprises administering an immunomodulatory nucleic acid to a subject suffering from or susceptible to gastrointestinal inflammation.
    Type: Application
    Filed: August 13, 2002
    Publication date: July 10, 2003
    Inventors: Eyal Raz, Daniel Rachmilewitz
  • Publication number: 20020042387
    Abstract: The invention provides a method for ameliorating gastrointestinal inflammation, particularly chronic gastrointestinal inflammation such as inflammatory bowel disease (IBD), in a subject. In one embodiment, the method comprises administering an immunomodulatory nucleic acid to a subject suffering from or susceptible to gastrointestinal inflammation.
    Type: Application
    Filed: February 22, 2001
    Publication date: April 11, 2002
    Inventors: Eyal Raz, Daniel Rachmilewitz